Brandes Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277M Sell
2,302,562
-164,963
-7% -$19M 1.96% 6
2025
Q4
$260M Buy
2,467,525
+44,858
+2% +$4.21M 1.98% 9
2025
Q3
$203M Buy
2,422,667
+510,439
+27% +$42M 1.63% 17
2025
Q2
$151M Buy
1,912,228
+95,978
+5% +$7.63M 1.37% 21
2025
Q1
$163M Buy
1,816,250
+283,535
+18% +$26.5M 1.66% 19
2024
Q4
$152M Buy
1,532,715
+154,510
+11% +$15.9M 1.7% 16
2024
Q3
$157M Buy
1,378,205
+18,439
+1% +$2.19M 1.76% 17
2024
Q2
$169M Buy
1,359,766
+127,240
+10% +$16.4M 2.08% 11
2024
Q1
$163M Buy
1,232,526
+103,377
+9% +$12.7M 2.09% 8
2023
Q4
$123M Buy
1,129,149
+140,301
+14% +$14.6M 1.87% 15
2023
Q3
$102M Buy
988,848
+48,574
+5% +$5.24M 1.99% 14
2023
Q2
$108M Sell
940,274
-5,787
-0.6% -$657K 2.19% 11
2023
Q1
$101M Buy
946,061
+68,383
+8% +$7.38M 2.14% 13
2022
Q4
$97.4M Sell
877,678
-317,550
-27% -$32.5M 2.73% 8
2022
Q3
$103M Sell
1,195,228
-309,095
-21% -$27.6M 2.69% 5
2022
Q2
$137M Sell
1,504,323
-20,183
-1% -$1.79M 3.35% 2
2022
Q1
$125M Buy
1,524,506
+66,575
+5% +$5.25M 2.68% 5
2021
Q4
$112M Buy
1,457,931
+9,377
+0.6% +$747K 2.44% 8
2021
Q3
$109M Buy
1,448,554
+45,015
+3% +$3.42M 2.36% 7
2021
Q2
$109M Buy
1,403,539
+354,996
+34% +$26.4M 2.43% 7
2021
Q1
$77M Buy
1,048,543
+192,093
+22% +$14.2M 1.82% 10
2020
Q4
$65.9M Sell
856,450
-7,430
-0.9% -$568K 1.7% 12
2020
Q3
$68.4M Sell
863,880
-139,880
-14% -$11M 2.36% 5
2020
Q2
$74.1M Sell
1,003,760
-147,456
-13% -$11.1M 2.25% 8
2020
Q1
$84.5M Sell
1,151,216
-54,590
-5% -$4.29M 2.96% 3
2019
Q4
$105M Sell
1,205,806
-49,770
-4% -$4.09M 2.49% 5
2019
Q3
$101M Sell
1,255,576
-125,188
-9% -$10M 2.61% 5
2019
Q2
$110M Sell
1,380,764
-78,301
-5% -$6M 2.46% 7
2019
Q1
$116M Sell
1,459,065
-61,406
-4% -$4.59M 2.69% 6
2018
Q4
$111M Sell
1,520,471
-266,636
-15% -$18.8M 2.82% 5
2018
Q3
$121M Sell
1,787,107
-35,175
-2% -$2.24M 2.73% 6
2018
Q2
$106M Sell
1,822,282
-30,741
-2% -$1.73M 2.38% 9
2018
Q1
$96.3M Buy
1,853,023
+132,295
+8% +$7.14M 2.06% 13
2017
Q4
$92.4M Buy
1,720,728
+45,200
+3% +$2.51M 1.87% 14
2017
Q3
$102M Sell
1,675,528
-619,642
-27% -$37.6M 2.08% 14
2017
Q2
$140M Sell
2,295,170
-436,039
-16% -$26.5M 2.22% 14
2017
Q1
$166M Sell
2,731,209
-88,373
-3% -$5.36M 2.46% 11
2016
Q4
$158M Sell
2,819,582
-127,727
-4% -$7.48M 2.38% 12
2016
Q3
$176M Sell
2,947,309
-83,417
-3% -$4.88M 2.63% 7
2016
Q2
$167M Sell
3,030,726
-113,335
-4% -$6.03M 2.55% 9
2016
Q1
$159M Sell
3,144,061
-13,114
-0.4% -$642K 2.27% 11
2015
Q4
$159M Buy
3,157,175
+231,176
+8% +$11.7M 2.33% 10
2015
Q3
$138M Sell
2,925,999
-26,713
-0.9% -$1.42M 2.02% 14
2015
Q2
$160M Buy
2,952,712
+624,275
+27% +$35M 2.05% 13
2015
Q1
$128M Sell
2,328,437
-89,131
-4% -$5.05M 1.76% 21
2014
Q4
$131M Sell
2,417,568
-14,094
-0.6% -$785K 1.85% 21
2014
Q3
$138M Sell
2,431,662
-119,726
-5% -$6.72M 1.82% 23
2014
Q2
$141M Sell
2,551,388
-17,391
-0.7% -$949K 1.7% 25
2014
Q1
$139M Sell
2,568,779
-26,280
-1% -$1.36M 1.76% 24
2013
Q4
$124M Sell
2,595,059
-237,656
-8% -$10.9M 1.53% 27
2013
Q3
$129M Sell
2,832,715
-595
-0% -$27.2K 1.66% 21
2013
Q2
$126M Buy
+2,833,310
New +$127M 1.57% 23

Other funds holding MRK

Brandes Investment Partners's MRK Position: Q1 2026 in Review

Brandes Investment Partners reduced its Merck (MRK) stake by 6.7% in Q1 2026, selling an estimated $19M and leaving 2,302,562 shares worth $277M. The position accounts for 1.96% of the portfolio, ranked #6.

Brandes Investment Partners first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Brandes Investment Partners held 2,302,562 shares of Merck worth $277M as of Q1 2026.
  • Brandes Investment Partners sold 164,963 Merck shares in Q1 2026, an estimated $19M.
  • Merck made up 1.96% of Brandes Investment Partners's portfolio in Q1 2026, its #6 holding.
  • Brandes Investment Partners first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.